WL, K., M, A., CB, H., B, V., S, F., SV, F., . . . RA, B. (2023). Selective neurodegeneration generated by intravenous α-synuclein pre-formed fibril administration is not associated with endogenous α-synuclein levels in the rat brain. Brain pathology (Zurich, Switzerland), 33(3), e13128. https://doi.org/10.1111/bpa.13128
Chicago Style (17th ed.) CitationWL, Kuan, Alfaidi M, Horne CB, Vallin B, Fox S, Fazal SV, Williams-Gray CH, and Barker RA. "Selective Neurodegeneration Generated by Intravenous α-synuclein Pre-formed Fibril Administration Is Not Associated with Endogenous α-synuclein Levels in the Rat Brain." Brain Pathology (Zurich, Switzerland) 33, no. 3 (2023): e13128. https://doi.org/10.1111/bpa.13128.
MLA (9th ed.) CitationWL, Kuan, et al. "Selective Neurodegeneration Generated by Intravenous α-synuclein Pre-formed Fibril Administration Is Not Associated with Endogenous α-synuclein Levels in the Rat Brain." Brain Pathology (Zurich, Switzerland), vol. 33, no. 3, 2023, p. e13128, https://doi.org/10.1111/bpa.13128.